Literature DB >> 15839907

The role of bisphosphonates in the treatment of prostate cancer.

Christopher C Parker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15839907     DOI： 10.1111/j.1464-410X.2005.05441.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  8 in total

1.  Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: a focus on zoledronic acid.

Authors:  Matti Aapro; Fred Saad
Journal:  Ther Adv Urol       Date:  2012-04

Review 2.  Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

Authors:  R G G Russell; N B Watts; F H Ebetino; M J Rogers
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507

Review 3.  Zoledronic acid : a review of its use in the management of bone metastases of malignancy.

Authors:  Sohita Dhillon; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.

Authors:  Brian L Foster; Kevin A Tompkins; R Bruce Rutherford; Hai Zhang; Emily Y Chu; Hanson Fong; Martha J Somerman
Journal:  Birth Defects Res C Embryo Today       Date:  2008-12

5.  Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment.

Authors:  Kristen D Brubaker; Lisha G Brown; Robert L Vessella; Eva Corey
Journal:  BMC Cancer       Date:  2006-01-17       Impact factor: 4.430

6.  Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas' sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation.

Authors:  Anthony S Malamas; Sofia R Gameiro; Karin M Knudson; James W Hodge
Journal:  Oncotarget       Date:  2016-12-27

7.  Use of bisphosphonates in prostate cancer: Current status.

Authors:  Rishi Nayyar; Narmada P Gupta
Journal:  Indian J Urol       Date:  2007-01

8.  Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.

Authors:  Johanna M Tuomela; Maija P Valta; Kalervo Väänänen; Pirkko L Härkönen
Journal:  BMC Cancer       Date:  2008-03-28       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.